Viewing nowCombinationTapagyn Plus Sustained Release Tablet 10/1000mg
Metformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Daehwa Pharmaceutical Co., Ltd.

MFDS item code 202300230 · Approved 2023.01.12 · Insurance code 645605780
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to aid the blood sugar control of adult patients with type 2 diabetes in conjunction with meal and exercise therapy through the combined administration of dapagliflozin and metformin. It is especially administered for patients whose blood sugar remains inadequately controlled and who have cardiovascular disease or risk factors, considering the risk of cardiovascular events. Therefore, this medication helps effectively improve blood sugar levels in patients with type 2 diabetes.
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, given as 2 tablets of 5mg/1000mg. Patients who have not previously received antidiabetic drug therapy and whose blood glucose is not adequately controlled with monotherapy: When used as initial therapy in patients who have not previously received antidiabetic drug therapy, the recommended starting dose of this medicine is 1 tablet of 5mg/500mg or 10mg/500mg once daily. Titrate the dose gradually to reduce gastrointestinal adverse effects of metformin. For patients receiving metformin, the recommended dose of dapagliflozin is 10mg once daily, and the dose of this medicine should provide the patient's current metformin dose or an appropriately titrated dose therapeutically equivalent to it. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted appropriately. For patients switching from concomitant dapagliflozin and metformin therapy to this medicine, the dose of this medicine may be initiated at the doses of dapagliflozin and metformin previously administered. When switching from immediate-release to extended-release metformin, blood glucose control should be closely monitored and the dose adjusted appropriately. When this medicine is used concomitantly with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. The safety and efficacy of this medicine have not been specifically evaluated in patients switching from other antihyperglycemic agents. Because such a change may result in changes in glycemic control, any change in treatment in patients with type 2 diabetes should be made under close monitoring. This medicine must be swallowed whole and must never be crushed, cut, or chewed. Occasionally, the inactive ingredients of this medicine may be excreted in the stool as a soft, hydrated mass resembling a tablet. Renal impairment No dose adjustment is required for patients with mild renal impairment. For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or greater and less than 60 mL/min/1.73 m2, who do not have other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, a component of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medicine is not recommended in patients with an eGFR of less than 45 mL/min/1.73m2. If the eGFR falls below 45 mL/min/1.73m2, this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months. Older adults Metformin is excreted by the kidneys, and older adults are more likely to have decreased renal function; therefore, this medicine should be used with caution as age increases (see Precautions for Use, 9. Administration to Older Adults).
This medication is used to treat diabetes and helps to control blood sugar levels. During treatment with this medication, very rarely, a serious condition known as lactic acidosis may occur, so caution is required. Lactic acidosis can lead to an excessive accumulation of lactic acid in the body, resulting in a dangerous condition, and can sometimes be life-threatening. Additionally, when taken with other diabetes medications such as insulin or sulfonylureas, hypoglycemic symptoms may occur, thus blood sugar levels should be closely monitored. Patients with impaired kidney function, dehydration, severe infections, or heart problems should not take this medication. Use of this drug is prohibited in patients with severe impairment of kidney function. If surgery is imminent or if there are plans for tests using iodine contrast agents, this medication should be temporarily discontinued for a period of time and only resumed after confirming that kidney function has returned to normal. Pregnant or nursing women should not take this medication, nor should patients with specific genetic disorders such as lactose intolerance. This medication may cause side effects such as reduced fluid volume, low blood pressure, and changes in kidney function; therefore, particularly in elderly patients or those with weak kidney function, it's essential to consult with a doctor before taking it and to undergo regular kidney function tests. During treatment, there may be occurrences of genital infections or urinary tract infections, so if any symptoms of infection appear, medical professionals should be notified immediately. This medication may also lower vitamin B12 levels, so if taken for an extended period, it is recommended to check vitamin B12 levels through blood tests. Excessive alcohol intake may increase the risk of side effects from this medication and should be avoided. During treatment, be alert for hypoglycemic symptoms, and if dizziness or weakness occurs, consult a doctor immediately. Finally, this medication has not been established as safe and effective for children, so it is not used in this population. It is important to consult with a physician or pharmacist before taking this medication to verify the appropriate usage and precautions corresponding to individual health conditions.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture, at a room temperature between 1 to 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be maintained for a longer period.
Yellow, double convex, oval-shaped sustained-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Daehwa Pharmaceutical Co., Ltd.
Metformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
Metformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication · Combination
AstraZeneca Korea Co., Ltd.
CombinationMetformin Hydrochloride 1000mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
YouYoung Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 500mg · Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication · Combination
Yuyoung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aju Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.